Welcome to our dedicated page for Charlottes Web news (Ticker: CWBHF), a resource for investors and traders seeking the latest updates and insights on Charlottes Web stock.
Charlotte's Web Holdings, Inc. (CWBHF) generates frequent news as a botanical wellness innovation company and market leader in hemp extract wellness and hemp-derived CBD wellness products. Headquartered in Louisville, Colorado and listed on the Toronto Stock Exchange under the symbol CWEB, the company issues regular updates on product launches, operational developments, financial results, and regulatory engagement.
News about Charlotte's Web often highlights new product introductions across CBD oil tinctures, CBD gummies, CBN and CBG gummies, hemp-derived THC microdose gummies, Brightside hemp-derived THC gummies, functional mushroom gummies, and CBD pet products for dogs. Recent announcements include the launch of Quiet Sleep Mushroom Gummies, a melatonin-free and cannabinoid-free sleep support product, and Knockout hemp THC sleep gummies under the Brightside brand, which use a rapid-onset delivery technology.
Investors and followers can also expect coverage of the company's financial performance through quarterly earnings releases, where Charlotte's Web discusses revenue trends, cost structure initiatives, and manufacturing internalization, particularly for gummy production. Additional news items describe the formation of a Scientific Advisory Board, expansion of the medical channel strategy, and participation in a Medicare and Medicaid Innovation pilot program to provide CBD options for senior oncology patients.
Regulatory and policy developments are another recurring theme. Charlotte's Web reports on federal and state-level hemp and CBD regulation, its involvement in industry coalitions such as ONE HEMP, and its perspective on proposed THC limits for hemp-derived products. Updates related to DeFloria, Inc., the Phase 2 clinical-stage botanical pharmaceutical company formed with AJNA BioSciences PBC and supported by a subsidiary of British American Tobacco plc, also appear in the news, including progress on AJA001 oral solution for irritability associated with autism spectrum disorder.
For investors, analysts, and consumers, the Charlotte's Web news feed provides ongoing insight into the company's product pipeline, strategic priorities, regulatory environment, and role in the evolving hemp and botanical wellness market.
Charlotte's Web Holdings announced the successful completion of its first international hemp harvest in Canada, using its proprietary hemp cultivars. The 2021 crop exceeded expectations by 20% and is set to supply the Canadian market in 2022. The CW1AS1 cultivar, vital for their Original Formula, will prioritize medical cannabis patients. The company aims to leverage its strong brand presence and strategic partnerships for distribution in Canada, focusing on a largely untapped hemp CBD market. This expansion may open doors for international sales of hemp biomass and extracts.
Charlotte's Web Holdings has launched two new oral sprays: Calm Spray and Sleep Spray, formulated with CBG and CBN to help manage stress and support sleep. Each 10mL spray costs $49.99 and contains proprietary THC-free hemp extract along with beneficial botanicals. The Calm Spray supports relaxation, while the Sleep Spray aids sleep cycles. Available exclusively on the e-commerce site initially, the products will be released nationwide in 2022. Vice President Reed Damon emphasized a faster go-to-market strategy and rigorous safety standards for these innovative products.
Charlotte's Web Holdings, Inc. has launched new Skin Health & Allergy Support Chews for dogs, designed to aid canine skin health during allergy seasons. The chews contain proprietary full-spectrum hemp extract and beneficial botanicals, including Biotin and Nettle Leaf. Available in chicken flavor, they come in 30-count ($19.99) and 60-count ($34.99) sizes. All products undergo rigorous testing for quality and safety. With skin issues being a common concern among pets, these chews offer a natural solution, leveraging CBD's proven safety for canines as confirmed by Colorado State University.
Charlotte's Web has achieved USDA organic certification for its corporate farm acreage and manufacturing facility, allowing select full-spectrum hemp extract tinctures to bear the USDA Organic Seal. This certification enhances the company's commitment to sustainable farming practices and quality standards. Customers can now purchase certified organic tinctures in various flavors and sizes, emphasizing the presence of beneficial nutrients. CEO Deanie Elsner remarked that this milestone reflects the company's continuous improvement and dedication to producing trusted hemp extract products.
Charlotte's Web Holdings is expanding its retail distribution in California following the passage of Assembly Bill 45 on October 6, allowing the sale of hemp-derived CBD products. This Law enables retailers in California to offer Charlotte's Web products amidst clear regulatory guidelines, enhancing consumer access to high-quality hemp dietary supplements. The company aims to increase product shipments to over 1,000 retail locations in the state, fostering economic opportunities and job creation within the hemp industry.
Charlotte's Web has expanded its gummy product line by introducing three new offerings: Daily Wellness, THC-Free, and Immunity gummies. These products will be available online and shipped to over 14,000 retail partners across the U.S. starting next month. The new gummies feature full-spectrum and broad-spectrum hemp extracts with varying CBD strengths and added vitamins for enhanced wellness. The CEO emphasized the importance of gummies as a leading delivery format in the rapid-growing hemp wellness sector. All products are vegan and non-GMO.
Charlotte's Web Holdings reported Q2 2021 financial results, showing a 11.4% year-over-year revenue growth to $24.2 million. Direct-to-consumer (DTC) revenue increased slightly by 1.0%, while business-to-business (B2B) revenue surged by 37.7%. Gross profit rose to 65.5% of revenue. The company reduced operating expenses by 15.2% and improved adjusted EBITDA losses to ($3.9 million). With $27.1 million in cash and $90.1 million in working capital, Charlotte's Web is positioned for growth in retail and the cannabis wellness market.
Charlotte's Web Holdings announced a collaborative research project with Colorado State University focusing on the phytochemical profile of hemp extracts. This first phase explores how genetic factors, environmental conditions, and extraction methods influence cannabinoid profiles in full-spectrum hemp extracts. Under the guidance of Dr. Jessica Prenni, the research aims to standardize chemical profiles for consistency. The project is part of Charlotte's Web's commitment to advancing scientific understanding of hemp, with phase I findings expected to be published after peer review.
Charlotte's Web has announced a multi-year exclusive agreement with Life Time, allowing its hemp CBD products to be sold at over 140 Life Time Athletic Clubs and during events across the U.S.
This partnership includes in-club signage and features in Experience Life magazine. Products will be available online at shop.lifetime.life. CEO Deanie Elsner emphasized the strategic fit with Life Time’s wellness mission, while Life Time’s Kimo Seymour noted Charlotte's Web's strong reputation in the CBD sector.
Charlotte's Web Holdings Inc. has appointed Tim Saunders to its Board of Directors, enhancing its governance and financial oversight. Saunders, former CFO of Canopy Growth, brings extensive experience, having managed over C$6.4 billion in financings and 31 acquisitions. He is expected to strengthen the company's expansion efforts into Canada, Israel, Europe, and the U.K. His broad insight into global markets will assist in navigating regulatory challenges as the company seeks growth in hemp and cannabis sectors.